Until now, specialists advised to administer the vaccine against the virus of the human papilloma virus (HPV) to the girls before they had their first sexual relation, although the recommendation extended to the young women, less than 26 years. A recent study revealed that prophylaxis was also effective in adult women over 26 years of age but, in the case of children, it was not considered advisable.
However, experts have found that HPV infection has been detected in a significant proportion of cancer cases. year Y vagina (at 80 percent), of penis Y vulva (40 percent), and also, although in a lower percentage, in oropharyngeal cancers in both sexes. For this reason, they consider that it would be appropriate for vaccination to be extended to children. With this measure, not only could cervical cancer be eradicated in the near future, but, in addition, the vaccinated population would benefit from additional protection against others tumors whose appearance is associated with the presence of this virus.
HPV infection has also been detected in a significant proportion of cancers of the anus, vagina, penis and vulva
Every year 2,000 new cases of uterine cancer are diagnosed in our country, a pathology that is very prevalent in women between 15 and 44 years old. The vaccine currently administered to girls in Spain protects against the four most harmful variants of the virus and, in the opinion of Xavier Bosch, head of the Cancer Epidemiology Program of the Catalan Institute of Oncology, would also serve as protection against other tumors in which HPV infection is implicated, hence the convenience of the vaccine being applied without distinction of sex.